Lochlan J Fennell

5PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 27, 2025
Receptor CDCP1 Is a Potential Target for Personalized Imaging and Treatment of Poor Outcome HER2+, Triple-Negative, and Metastatic ER+/HER2- Breast Cancers.

Madeline Gough, Kayden K X Kwah, Tashbib Khan

|May 10, 2020
<i>APC</i> Mutation Marks an Aggressive Subtype of <i>BRAF</i> Mutant Colorectal Cancers.

Lochlan J Fennell, Alexandra Kane, Cheng Liu

|Jun 16, 2019
DNA methylation changes that precede onset of dysplasia in advanced sessile serrated adenomas.

Cheng Liu, Lochlan J Fennell, Mark L Bettington

|Jul 29, 2017
Sessile serrated adenomas with dysplasia: morphological patterns and correlations with MLH1 immunohistochemistry.

Cheng Liu, Neal I Walker, Barbara A Leggett

Pageof 1